IBEX Limited Q4 2026 Earnings Call Summary

IBEX Limited's Q4 2026 earnings call revealed strong financial performance and strategic initiatives. The company achieved its sixth consecutive quarter of double-digit revenue growth, exceeding $100 million in annual revenue for the HealthTech vertical. IBEX formed a strategic partnership with Sierra AI to deploy AI agents that exceeded 20% to 40% resolution rates while maintaining customer satisfaction scores.

The "land and expand" model helped win traditional human agent business after initially deploying AI solutions. AI agents captured unhandled call volume, converting it into incremental sales opportunities. Management expects FY27 revenue growth of 9% to 11%, with AI agent deployments reaching full scale faster than traditional human agents.

The normalized tax rate is projected to stabilize between 20% and 22%. The company exited emerging growth status, initiating SOC certification for financial reporting. AI is not cannibalizing revenue but differentiating IBEX from traditional BPOs, allowing them to win human agent market share. The Q4 rate was lower due to a favorable tax resolution.

HealthTech growth is driven by large payers and specialty niches, while retail and e-commerce growth is fueled by low-price markets like Pakistan. IBEX's guidance for FY27 anticipates strong performance in HealthTech and rapid AI agent deployment.